Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Humanized anti-cocaine MAb demonstrates in vivo efficacy

April 30, 2013

Lundbeck launches Selincro in European markets

April 22, 2013

PharmAthene's rBChE shown to bind to broad spectrum of nerve agents

April 19, 2013

NeoStem receives second year of grant for very small embryonic-like stem cells

April 3, 2013

New agents for substance abuse and dependence divulged by Gilead Sciences

March 27, 2013

FDA committee recommends approval of Probuphine

March 22, 2013

Omeros identifies mechanism of action of its PDE7 inhibitors in addiction

March 21, 2013

Researchers develop novel animal models of pediatric OP-induced SE

March 21, 2013

Lundbeck's Selincro approved in E.U. for alcohol dependence

March 1, 2013

MediciNova's MN-166 gets fast track designation from FDA

Feb. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...